Internal Medicine, Hematology & Oncology · San Diego, CA
NPI
1407159726
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
402 Dickinson St, Suite 380
San Diego, CA, 92103
Phone (619) 290-7497
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
589 services
Medicare patients, 2024
125
Average age 73
Drug cost, 2024
$1.8M
604 prescriptions
Company payments, 2025
$15K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tiffany N Tanaka was code 99233 (hospital e&m - subsequent), 300 times for 53 patients. In total Tiffany N Tanaka billed 589 services in 16 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 300 | 53 | $94.27 | $28K |
| 99215 Office E&M - Established | Facility | 128 | 49 | $112.23 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 41 | 16 | $13.17 | $540 |
| 99214 Office E&M - Established | Facility | 35 | 29 | $73.04 | $2,556 |
| 99239 Hospital Discharge Management | Facility | 18 | 17 | $93.68 | $1,686 |
By year: 2022 $30K for 351 services; 2023 $49K for 505 services; 2024 $54K for 589 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tiffany N Tanaka prescribed most often to Medicare patients was Acyclovir, with 58 prescriptions and refills. In total Tiffany N Tanaka wrote 604 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 58 | 97 | 19 | $1,021 |
| Hydroxyurea Generic | 58 | 160 | 15 | $2,258 |
| Bosulif Bosutinib | 37 | 37 | Under 11 | $612K |
| Imatinib Mesylate Generic | 28 | 28 | Under 11 | $19K |
| Jakafi Ruxolitinib Phosphate | 26 | 26 | Under 11 | $490K |
| Venclexta Venetoclax | 22 | 22 | Under 11 | $94K |
| Droxia Hydroxyurea | 17 | 23 | Under 11 | $501 |
| Cresemba Isavuconazonium Sulfate | 17 | 17 | Under 11 | $99K |
| Eliquis Apixaban | 16 | 24 | Under 11 | $14K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 16 | 28 | Under 11 | $36.43 |
| Levofloxacin Generic | 16 | 16 | 11 | $158 |
| Ondansetron Hcl Generic | 14 | 14 | Under 11 | $288 |
| Entecavir Generic | 14 | 25 | Under 11 | $2,143 |
| Fluconazole Generic | 13 | 16 | Under 11 | $702 |
| Valacyclovir Valacyclovir Hcl | 13 | 13 | Under 11 | $322 |
Brand drugs: - claims; generic drugs: 395 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tiffany N Tanaka $15K ($15K in general payments such as food, travel and fees) from 3 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $7,163.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.